CHEK2 and breast carcinoma: In studies from China [37] and Turkey [38], CHEK2 p.(Tyr390 Cys) missense variant was associated with breast cancer and was predicted to be most likely deleterious by Align-GVGD and SIFT and probably damaging by Poly-Phen2 [38].